The Chronic Graft-vs.-Host Disease Failure-Free Survival (cGVHD-FFS) index

In clinical trials of chronic graft-versus-host disease (GVHD), the need to start a new systemic treatment is considered a treatment failure. A composite endpoint called “failure-free survival” (FFS) where events are initiation of a new systemic chronic GVHD treatment, recurrent malignancy, and deat...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Biol Blood Marrow Transplant
Asıl Yazarlar: Pidala, Joseph A., Hamilton, Betty K., Martin, Paul J., Onstad, Lynn, Storer, Barry E., Palmer, Jeanne, Alousi, Amin, Cutler, Corey, Jagasia, Madan H., Chen, George L., Arora, Mukta, Flowers, Mary E., Lee, Stephanie J.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2019
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6900444/
https://ncbi.nlm.nih.gov/pubmed/31394265
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2019.07.040
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller